Health Condition 1: N181- Chronic kidney disease, stage 1
Conditions
Interventions
Intervention1: Shuddhi Dr. Kidney Care Tablets: Test Product: Shuddhi Dr. Kidney Care Tablets
Dose: 1-1 Tablet (TID)
Route of Administration: Oral, Duration: 30Days
Control Intervention1: Not Applica
Sponsors
Jeena Sikho Lifecare Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subject from 18-70 years of age. 2. Subject having GFR range less than 60mg/ml will be eligible for enrollment. 3. Subjects that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study. 4. Subject willing to avoid participation in any other interventional clinical trial for the duration of the study.
Exclusion criteria
Exclusion criteria: 1. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including oral or parenteral corticosteroids. 2. Subjects that have participated in any other interventional clinical trial in the previous 90 days. 3. Subjects with known sensitivity to any of the constituents of the investigational product. 4. Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures. 5. Chronic illness which may influence the outcome of the study. 6. Pregnant/nursing mothers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Change in KFT 2. Change in CBC 3. Change in Urine Test 4. Change in Subject Global AssessmentTimepoint: At T+1day, T+30days | — |
Secondary
| Measure | Time frame |
|---|---|
| Not ApplicableTimepoint: Not Applicable | — |
Countries
India
Contacts
Public ContactPuneet Mittal
CCFT Laboratories
Outcome results
None listed